Retratrutide | 5 mg
Retratrutide | 5 mg
For research purposes only – no human use.
Retatrutide | 5mg
Retatrutide is supplied strictly as a laboratory research material for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in‑vitro research, assay development, method validation, and controlled scientific investigation by appropriately qualified professionals.
Product details
- Product: Retatrutide
- Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Strength / size: Retatrutide 5 Mg
- Category: Research compound / research peptide
- Form: Lyophilised powder
- Use: Laboratory research only
- Supply: Perth & Western Australia (AU shipping)
Retatrutide is a novel experimental peptide currently being studied for its potential to significantly impact metabolic health. In simple terms, it’s a synthetic compound designed to mimic and activate multiple natural hormone pathways in the body that regulate appetite, energy use, and blood sugar levels.
Unlike many existing peptides that target a single receptor, Retatrutide is a triple agonist. This means it simultaneously activates three key receptors:
- GLP-1 (Glucagon-Like Peptide-1) – involved in reducing appetite, slowing digestion, and improving insulin secretion.
- GIP (Glucose-Dependent Insulinotropic Polypeptide) – works with GLP-1 to further enhance insulin response and support fat metabolism.
- Glucagon receptor – helps increase energy expenditure and fat burning when activated in a controlled way.
By engaging these three pathways at once, Retatrutide has demonstrated promising effects in early studies, particularly for weight reduction and glucose regulation. Research suggests that this multi-target approach may deliver greater metabolic benefits than single-receptor peptides like semaglutide or tirzepatide.
